Cargando…
Impact of co-morbidity on reoperation or death within 90 days of surgery for oesophageal cancer
BACKGROUND: The impact of preoperative co-morbidity on postoperative outcomes in patients with oesophageal cancer is uncertain. A population-based and nationwide cohort study was conducted to assess the influence of preoperative co-morbidity on the risk of reoperation or mortality within 90 days of...
Autores principales: | Cheng, Z, Johar, A, Gottlieb-Vedi, E, Nilsson, M, Lagergren, J, Lagergren, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893455/ https://www.ncbi.nlm.nih.gov/pubmed/33609378 http://dx.doi.org/10.1093/bjsopen/zraa035 |
Ejemplares similares
-
Lymphadenectomy and risk of reoperation or mortality shortly after surgery for oesophageal cancer
por: Lagergren, Jesper, et al.
Publicado: (2016) -
Reoperation after oesophageal cancer surgery in relation to long-term survival: a population-based cohort study
por: van der Schaaf, Maartje, et al.
Publicado: (2014) -
Impact of co‐morbidities on health‐related quality of life 10 years after surgical treatment of oesophageal cancer
por: Klevebro, F., et al.
Publicado: (2020) -
Lymphadenectomy and health-related quality of life after oesophageal cancer surgery: a nationwide, population-based cohort study
por: Schandl, Anna, et al.
Publicado: (2016) -
The prognostic role of coeliac node metastasis after resection for distal oesophageal cancer
por: Rutegård, Martin, et al.
Publicado: (2017)